140 related articles for article (PubMed ID: 2540562)
41. Diagnosis of renal allograft rejection by analysis of infiltrating cell profiles: an assessment of cyclosporine, azathioprine/prednisolone, and triple therapy.
McWhinnie DL; Azevedo LS; Carter NP; Cranston D; Jones R; Wood RF; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1633-4. PubMed ID: 3152633
[No Abstract] [Full Text] [Related]
42. Suppression of second-set rejection by cyclosporine-resistant suppressor cells in a rat renal allograft model.
Freitas Rodrigues MA; Hutchinson IV; Morris PJ
Transplant Proc; 1989 Feb; 21(1 Pt 1):365-6. PubMed ID: 2523135
[No Abstract] [Full Text] [Related]
43. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
44. Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts.
Azuma H; Tomita N; Kaneda Y; Koike H; Ogihara T; Katsuoka Y; Morishita R
Gene Ther; 2003 Mar; 10(5):415-25. PubMed ID: 12601396
[TBL] [Abstract][Full Text] [Related]
45. Dose response of cyclosporine-treated composite tissue allografts in a strong histoincompatible rat model.
Black KS; Hewitt CW; Hwang JS; Borger RW; Achauer BM
Transplant Proc; 1988 Apr; 20(2 Suppl 2):266-8. PubMed ID: 3259040
[No Abstract] [Full Text] [Related]
46. Induction of long-term rat renal allograft survival: a specific synergistic effect of limited pretransplant cyclosporine combined with multiple nonspecific blood transfusions.
Martin DC; Hewitt CW; Black KS; Reyes M; Go C
Transplant Proc; 1987 Feb; 19(1 Pt 1):462-3. PubMed ID: 3274807
[No Abstract] [Full Text] [Related]
47. Some experimental and clinical studies of Cyclosporin A in renal transplantation.
Morris PJ
Transplant Proc; 1982 Sep; 14(3):525-8. PubMed ID: 6758238
[No Abstract] [Full Text] [Related]
48. Triple low-dose immunosuppression with cessation of steroids in pediatric renal transplantation.
Walker RG; d'Apice AJ; Powell HR; Francis DM; Kincaid-Smith P
Transplant Proc; 1988 Feb; 20(1):7-10. PubMed ID: 3278465
[No Abstract] [Full Text] [Related]
49. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
[No Abstract] [Full Text] [Related]
50. Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?
Melzer JS; Husing RM; Feduska NJ; Tomlanovich SJ; Vincenti F; Amend WJ; Garovoy M; Salvatierra O
Transplant Proc; 1987 Feb; 19(1 Pt 3):1971-3. PubMed ID: 2856274
[No Abstract] [Full Text] [Related]
51. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
[No Abstract] [Full Text] [Related]
52. Induction of cyclo-oxygenase-2 by acute liver allograft rejection and cytomegalovirus infection in the rat.
Martelius TJ; Wolff H; Bruggeman CA; Höckerstedt KA; Lautenschlager IT
Transpl Int; 2002 Dec; 15(12):610-4. PubMed ID: 12478407
[TBL] [Abstract][Full Text] [Related]
53. Allogeneic small bowel transplantation with cyclosporine and donor whole-body irradiation.
Frantz FW; Terris DJ; Wyble CW; Halperin EC; Sanfilippo F; Scroggs MW; Honoré G; Bollinger RR
Transplant Proc; 1988 Feb; 20(1 Suppl 1):193-6. PubMed ID: 3279610
[No Abstract] [Full Text] [Related]
54. Effect of kidney perfusion on renal allograft survival in azathioprine treated rats.
Lameijer LD; Smith J; Mowbray JF
Br J Exp Pathol; 1972 Apr; 53(2):130-7. PubMed ID: 4555713
[TBL] [Abstract][Full Text] [Related]
55. Donor seropositivity and prednisolone therapy as risk factors for cytomegalovirus infection and disease in cyclosporin-treated renal allograft recipients.
Morris DJ; Longson M; Poslethwaite RJ; Mallick NP; Johnson RW
Q J Med; 1990 Nov; 77(283):1165-73. PubMed ID: 2177208
[TBL] [Abstract][Full Text] [Related]
56. Is a dose reduction of pulsed steroids feasible for treatment of cardiac allograft rejection beyond 6 months?
Wahlers T; Heublein B; Cremer J; Fieguth HG; Albes J; Kemnitz J; Haverich A; Borst HG
Transplant Proc; 1990 Aug; 22(4):1440. PubMed ID: 2389354
[No Abstract] [Full Text] [Related]
57. [Effect of high-dosage prednisolone administration on interstitial transplantation edema following allogeneic kidney transplantation in rats].
Wagner E; Schweitzer J; Gertz KH
Chir Forum Exp Klin Forsch; 1979; ():313-7. PubMed ID: 378591
[TBL] [Abstract][Full Text] [Related]
58. Relevance of maintenance triple-drug immunosuppression to bridle the amplification of rat cytomegalovirus infection after experimental lung transplantation.
Lehle K; von Suesskind-Schwendi M; Diez C; Michl M; Geissler EK; Wottge HU; Schmid C; Hirt SW
Transpl Infect Dis; 2012 Dec; 14(6):649-56. PubMed ID: 22676701
[TBL] [Abstract][Full Text] [Related]
59. The effect of cytomegalovirus infection on renal allograft function and rejection in a rat model.
Bruning JH; Bruggeman CA; van Breda Vriesman PJ
Transplantation; 1989 Apr; 47(4):742-4. PubMed ID: 2539666
[No Abstract] [Full Text] [Related]
60. The role of alloresponsive Ly49+ NK cells in rat islet allograft failure in the presence and absence of cytomegalovirus.
Smelt MJ; Faas MM; de Haan BJ; de Haan A; Vaage JT; de Vos P
Cell Transplant; 2014; 23(11):1381-94. PubMed ID: 23866824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
